UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

By R. Peto, J. Boreham, M. Clarke, C. Davies, V. Beral. The Lancet, 2000

689 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Oncology

View Paper: https://www.semanticscholar.org/paper/682fac117463def2fe058bd2c6b0a34b3fd3d27c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. A. Jemal
2. Mitchell Dowsett
3. D. M. Parkin
4. Lisa A. Carey

In Genetics

1. Mitchell Dowsett
2. F. Bray
3. A. Jemal
4. D. M. Parkin

In Oncology

1. A. Jemal
2. F. Bray
3. Jiemin Ma
4. D. M. Parkin
5. R. Siegel
6. J. Ferlay
7. Isabelle Soerjomataram
8. K. Miller

Citations in the corpus

• Mechanisms of tamoxifen resistance. (2004, background): “…an adjuvant therapy in early breast cancer tamoxifen improves overall survival, and its widespread use is thought to have made a significant contribution to the reduction in breast cancer mortality seen over the last decade (Early Breast Cancer Trialists’ Collaborative Group 1998, Peto et al. 2000).”
• Molecular classification and molecular forecasting of breast cancer: ready for clinical application? (2005, background): “breast cancer mortality is decreasing in most of the Western world.(1) The recent overview”
• The changing global patterns of female breast cancer incidence and mortality (2004, background): “A levelling off and subsequent decline in breast cancer mortality from the early 1990s became evident in England and Wales [9,27,28] and The Netherlands [27] and has now also been observed in several other European countries [14], although the declines are often confined to women aged less than 50 y”
• Endocrine-responsive breast cancer and strategies for combating resistance (2002, background): “These discoveries have contributed considerably to the marked reduction in mortality caused by breast cancer in the past decad”
• Breast Cancer Statistics (2013, background): “The decreasing trends in these countries have been attributed to improved breast awareness, extended use of mammographic screening, intensified early clinical diagnosis, and advances in both primary and adjuvant treatments for breast cancer [51].”